A Review of the Phase 3 MAESTRO Trials for Resmetirom in Metabolic Function Associated Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease (NAFLD), is the leading cause of chronic liver disease in the United States. It encompasses liver conditions characterized by fat accumulation without excessive alcohol consumption. Early symptoms such as fatigue and abdominal pain are nonspecific, leading to delayed diagnosis until severe complications arise. 

• Fulltext Article